BioXcel Therapeutics, Inc. reports acquisition or asset disposition

BioXcel Therapeutics, Inc. filed an 8-K covering an acquisition or disposition of assets, director or executive-officer changes, and charter, bylaw or fiscal-year changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.